1. Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma. Issue 10 (October 2014) Authors: Dakhil, Shaker; Hermann, Robert; Schreeder, Marshall T.; Gregory, Stephanie A.; Monte, Marc; Windsor, Kevin S.; Hurst, Deborah; Chai, Akiko; Brewster, Michael; Richards, Paul Journal: Leukemia & lymphoma Issue: Volume 55:Issue 10(2014:Oct.) Page Start: 2335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗